In brief
Key points
- ✓Medical prescription
- ✓Device training
- ✓Dose log
- ✓Scheduled reviews
Before starting
The device, distance, exposure area, eye protection, dose increases and action after a missed session must be demonstrated clearly.
When to pause
Unexpected or persistent redness, pain, blistering or uncertainty about dosing requires stopping and contacting the treating service.
Editorial basis: current AWMF S2k guideline on the diagnosis and treatment of vitiligo, register 013-093, version 2.0 dated 27 July 2026. Reviewed on 2 September 2026.
Commercial links are limited to approved IDEALDERM product information.